DNA signals for G2 checkpoint response in diploid human fibroblasts

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 400, Issue 1-2, 1998, Pages 153-167

  Kaufmann, William K ^a,b   Kies, Paula E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Diploid human fibroblast; DNA (deoxyribonucleic acid); G2

Indexed keywords

2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; ANTINEOPLASTIC AGENT; APHIDICOLIN; BLEOMYCIN; CAMPTOTHECIN; DNA TOPOISOMERASE INHIBITOR; DOUBLE STRANDED DNA; ETOPOSIDE; GYRASE INHIBITOR; MATURATION PROMOTING FACTOR; PHOSPHOTRANSFERASE; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DIPLOIDY; DNA STRAND BREAKAGE; DNA SYNTHESIS INHIBITION; EXCISION REPAIR; FIBROBLAST; GAMMA IRRADIATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; ULTRAVIOLET C RADIATION;

CALIBRATION; CAMPTOTHECIN; CELLS, CULTURED; CHROMATOGRAPHY; CHROMOSOME BREAKAGE; DIPLOIDY; DNA; DNA DAMAGE; FIBROBLASTS; G2 PHASE; HUMANS; MITOSIS;

EID: 0032565519     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00041-4     Document Type: Article

References (64)

1. [1] L.H. Hartwell, M.B. Kastan, Cell cycle control and cancer, Science 266 (1994) 1821-1828.
2. [2] W.K. Kaufmann, R.S. Paules, DNA damage and cell cycle checkpoints, FASEB J. 10 (1996) 238-247.
3. [3] A.G. Paulovich, D.P. Toczycki, L.H. Hartwell, When checkpoints fail, Cell 88 (1997) 315-321.
4. [4] S.C. Downes, D.J. Clarke, A.M. Mullinger, J.F. Gimenez-Abian, A.M. Creighton, R.T. Johnson, A topoisomerase II-dependent G2 checkpoint in mammalian cells, Nature 372 (1994) 467-470.
5. [5] P.R. Andreassen, F.B. Lacroix, R.L. Margolis, Chromosomes with two intact axial cores are induced by G2 checkpoint override: evidence that DNA decatenation is not required to template the chromosome structure, J. Cell Biol. 136 (1997) 29-43.
6. [6] D.J. Clarke, R.T. Johnson, S.T. Downes, Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks, J. Cell Sci. 105 (1993) 563-569.
7. [7] R. Ishida, M. Sato, T. Narita, K.R. Utsumi, T. Nishimoto, T. Morita, H. Nagata, T. Andoh, Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events, J. Cell Biol. 126 (1994) 1341-1351.
8. [8] A. DiLeonardo, S.P. Linke, K. Clarkin, G.M. Wahl, DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts, Genes Dev. 8 (1994) 2540-2551.
9. [9] S.P. Linke, K.C. Clarkin, G.M. Wahl, P53 mediates permanent arrest over multiple cell cycles in response to γ-irradiation, Cancer Res. 57 (1997) 171-1179.
10. [10] L.H. Hartwell, Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells, Cell 13 (1992) 543-546.
11. [11] W.K. Kaufmann, D.G. Kaufman, Cell cycle control, DNA repair and initiation of carcinogenesis, FASEB J. 7 (1993) 1188-1191.
12. [12] C. Norbury, P. Nurse, Animal cell cycles and their control, Annu. Rev. Biochem. 61 (1992) 441-470.
13. [13] E. Nigg, Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle, BioEssays 17 (1995) 471-480.
14. [14] D.O. Morgan, Principles of CDK regulation, Nature 374 (1995) 131-134.
15. [15] H. Lu, R.P. Fisher, P. Bailey, A.J. Levine, The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA-binding activity in vitro, Mol. Cell. Biol. 17 (1997) 5923-5934.
16. [16] C.H. McGowan, P. Russell, Cell cycle regulation of human WEE1, EMBO J. 14 (1995) 2166-2175.
17. [17] M.J. O'Connell, J.M. Raleigh, H.M. Verkade, P. Nurse, Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation, EMBO J. 16 (1997) 545-554.
18. [18] S. Kharbanda, Z.M. Yean, E. Rubin, R. Weichselbaum, D. Kufe, Activation of Src-like p56/p531yn tyrosine kinase by ionizing radiation, J. Biol. Chem. 269 (1994) 20739-20743.
19. [19] P.R. Mueller, T.R. Coleman, A. Kumagai, W.G. Dunphy, Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15, Science 270 (1995) 86-90.
20. [20] I. Hoffman, P.R. Clarke, M.J. Marcote, E. Karsenti, G. Draetta, Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis, EMBO J. 12 (1993) 53-63.
21. [21] P.M. O'Connor, D.K. Ferris, I. Hoffmann, J. Jackman, G. Draetta, K.W. Kohn, Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard, PNAS (USA) 91 (1994) 9480-9484.
22. [22] R.S. Paules, E.N. Levedakou, S.J. Wilson, C. Innes, N. Rhodes, T.D. Tlsty, D.A. Galloway, L.A. Donehower, M.A. Tainshy, W.K. Kaufmann, Defective G2 checkpoint function in cells from individuals with familial cancer syndromes, Cancer Res. 55 (1995) 1763-1773.
23. [23] C.-Y. Peng, P.R. Graves, R.S. Thoma, Z. Wu, A.S. Shaw, H. Piwnica-Worms, Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of cdc25c on serine-216, Science 277 (1997) 1501-1505.
24. [24] B. Funari, N. Rhind, P. Russell, Cdc25 mitotic inducer targeted by Chk1 DNA damage checkpoint kinase, Science 277 (1997) 1495-1497.
25. [25] H. Barth, I. Hoffman, V. Kinzel, Radiation with 1 Gy prevents the activation of the mitotic inducers, mitosis-promoting factor (MPF) and cdc25c, in HeLa cells, Cancer Res. 56 (1996) 2268-2272.
26. cdc2 kinases in irradiated human B-cell precursors, J. Biol. Chem. 271 (1996) 6389-6397.
27. [27] D. Scott, F. Zampetti-Bosseler, Relationships between chromosome damage, cell cycle delay and cell killing induced by bleomycin or X-rays, Mutation Res. 151 (1985) 83-88.
28. [28] P.M. O'Connor, D.K. Ferris, G.A. White, J. Pines, T. Hunter, D.L. Longo, K.W. Kohn, Relationships between cdc2 kinase, DNA crosslinking, and cell cycle perturbations induced by nitrogen mustard, Cell Growth Differ. 3 (1992) 43-52.
29. [29] W.K. Kaufmann, J.L. Schwartz, J.C. Hurt, L.L. Byrd, D.A. Galloway, E. Levedakou, R.S. Paules, Inactivation of G2 checkpoint function and chromosomal destabilization are linked in human fibroblasts expressing human papillomavirus type 16 E6, Cell Growth Differ. 8 (1997) 1105-1114.
30. [30] W.G. Nelson, M.B. Kastan, DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways, Mol. Cell. Biol. 14 (1994) 1815-1823.
31. [31] W.K. Kaufmann, S.J. Wilson, DNA repair endonuclease activity during synchronous growth of diploid human fibroblasts, Mutation Res. 236 (1990) 107-117.
32. [32] T.D. Stamato, N. Denko, Asymmetric field inversion gel electrophoresis: a new method for detecting DNA double-strand breaks in mammalian cells, Radiat. Res. 121 (1990) 196-205.
33. [33] D. Blocher, M. Einspenner, J. Zajackowski, CHEF electrophoresis, a sensitive technique for the determination of DNA double-strand breaks, Int. J. Radiat. Biol. 56 (1989) 437-448.
34. [34] M.O. Bradley, K.W. Kohn, X-ray induced DNA double strand break production and repair in mammalian cells as measured by neutral filter elution, Nucleic Acids Res. 7 (1979) 793-804.
35. [35] L.F. Povirk, DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enediynes, Mutation Res. 355 (1996) 71-89.
36. [36] Y.-P. Tsao, P. D'Arpa, L.F. Liu, The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B, Cancer Res. 52 (1992) 1823-1829.
37. [37] G.L. Chen, L. Yang, T.C. Rowe, B.D. Halligan, K.M. Tewey, L.F. Liu, Non-intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II, J. Biol. Chem. 259 (1984) 13560-13566.
38. [38] J. Roca, R. Ishida, J.M. Berger, T. Andoh, J.C. Wang, Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp, PNAS (USA) 91 (1994) 1781-1785.
39. [39] F. Goldwasser, T. Shimizu, J. Jackman, Y. Hoki, P.M. O'Connor, K.W. Kohn, Y. Pommier, Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells, Cancer Res. 56 (1996) 4430-4437.
40. [40] W.K. Kaufmann, J.C. Boyer, L.L. Estabrooks, S.J. Wilson, Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes, Mol. Cell. Biol. 11 (1991) 3711-3718.
41. [41] L.H. Hartwell, T.A. Weinert, Checkpoints: controls that ensure the order of cell cycle events, Science 246 (1989) 629-634.
42. [42] B. Drewinko, B. Barlogie, Survival and cycle-progression delay of human lymphoma cells in vitro exposed to VP-16-213, Cancer Treat. Rep. 60 (1976) 1295-1306.
43. [43] R.B. Lock, W.E. Ross, Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster cells, Cancer Res. 50 (1990) 3761-3766.
44. [44] R.B. Lock, Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide, Cancer Res. 52 (1992) 1817-1822.
45. [45] B.H. Long, S.T. Musial, M.G. Brattain, Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide, Cancer Res. 45 (1985) 3106-3112.
46. [46] R. Ishida, T. Miki, T. Narita, R. Yui, M. Sato, K.R. Utsumi, K. Tanabe, T. Andoh, Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors, Cancer Res. 51 (1991) 4909-4916.
47. [47] K. Tanabe, Y. Ikegami, R. Ishida, T. Andoh, Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives, Cancer Res. 51 (1991) 4903-4908.
48. [48] M.O. Bradley, V.I. Taylor, Repair-induced DNA double strand breaks after ultraviolet-light and either aphidicolin or 1-β-D-arabinofuranosylcytosine/hydroxyurea, Carcinogenesis 12 (1983) 1513-1517.
49. [49] W.K. Kaufmann, S.J. Wilson, G1 arrest and cell-cycle-dependent clastogenesis in UV-irradiated human fibroblasts, Mutation Res. 314 (1994) 67-76.
50. [50] D.K. Orren, L.N. Petersen, V.A. Bohr, A UV-responsive G2 checkpoint in rodent cells, Mol. Cell. Biol. 15 (1995) 3722-3730.
51. [51] C. Rosette, M. Karin, Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors, Science 274 (1996) 1194-1197.
52. [52] V. Kinzel, M. Kaszkin, A. Blume, J. Richards, Epidermal growth factor inhibits transiently the progression from G2-phase to mitosis: a receptor-mediated phenomenon in various cells, Cancer Res. 50 (1990) 7932-7936.
53. [53] T. Herzinger, J.O. Funk, K. Hillmer, D. Eick, D.A. WIf, P. Kind, Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase, Oncogene 11 (1995) 2151-2156.
54. [54] E.G. Gabrielli, J.M. Clark, A.K. McCormack, K.A.O. Ellem, Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis, Oncogene 15 (1997) 749-758.
55. [55] R.Y.C. Poon, W. Jiang, H. Toyoshima, T. Hunter, Cyclin-dependent kinases are inactivated by a combination of p21 and thr-14/tyr-15 phosphorylation after UV-induced DNA damage, J. Biol. Chem. 271 (1996) 13283-13291.
56. [56] J.C. Wang, DNA topoisomerases, Annu. Rev. Biochem. 54 (1985) 665-697.
57. [57] A.J. Ryan, S. Squires, H.L. Strutt, A. Evans, R.T. Johnson, Different fates of camptothecin-induced replication fork-associated double-strand DNA breaks in mammalian cells, Carcinogenesis 15 (1994) 823-828.
58. [58] T. Enoch, P. Nurse, Mutation of fission yeast cell cycle control genes abolishes dependence of mitosis on DNA replication, Cell 60 (1990) 665-673.
59. [59] T.A. Navas, Z. Zhou, S.J. Elledge, DNA polymerase ε links the DNA replication machinery to the S-phase checkpoint, Cell 80 (1995) 29-39.
60. [60] G. D'Urso, P. Nurse, Schizosaccharomyces pombe cdc20 + encodes DNA polymerase, ε, and is required for chromosomal replication but not for the S-phase checkpoint, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 12491-12496.
61. [61] J. Wuarin, P. Nurse, Regulating S-phase: CDKs, licensing and proteolysis, Cell 85 (1996) 785-787.
62. [62] C.J. Sherr, Cancer cell cycles, Science 274 (1996) 1672-1677.
63. [63] R. Schlegel, A.B. Pardee, Caffeine-induced uncoupling for mitosis from the completion of DNA replication in mammalian cells, Science 232 (1986) 1264-1266.
64. [64] M. Ohtsubo, R. Kai, N. Furuno, T. Sekiguchi, M. Sekiguchi, H. Hayashida, K. Kuma, T. Miyata, S. Fukushige, T. Murotsu, Isolation and characterization of the active cDNA of the human cell cycle gene (RCC1) involved in the regulation of onset of chromosome condensation, Genes Dev. 1 (1987) 585-593.